Skip to main content

Valproic Acid News

Autism Risk May Rise With In Utero Exposure to Antiseizure Meds

WEDNESDAY, March 20, 2024 – The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy compared with the general population of children...

Prenatal Valproate Exposure Tied to Psychiatric Disorders in Late Childhood

WEDNESDAY, May 24, 2023 – Prenatal exposure to the antiepileptic medication valproate is associated with an increased risk for later psychiatric disorders among children of mothers with epilepsy,...

FDA Medwatch Alert: Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics ISSUE: FDA is advising health care...

FDA Medwatch Alert: Valproate Products: Drug Safety Communication - Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)

Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics ISSUE: FDA notified healthcare professionals...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bipolar Disorder, Epilepsy, Seizures, Seizure Prevention, Seizure Prophylaxis, Headache, Mania, Migraine, Migraine Prevention, Migraine Prophylaxis, Schizoaffective Disorder

Valproic Acid patient information at Drugs.com